Patients with newly diagnosed type 2 diabetes had equal improvement in HbA1c whether they self-monitored by testing their blood or urine glucose, a study found.
Among sulfonylureas, gliclazide and glimepiride were associated with a lower risk of all-cause and cardiovascular-related mortality than glyburide, a meta-analysis found.
Through accurate coding, electronic medical records (EMRs) may help improve diagnosis of diabetes and quality of care, according to a recent study.
A large meta-analysis recently compared the effectiveness of pharmacological treatments for painful diabetic neuropathy.
Random or fasting glucose measurements can be used to screen for diabetes in patients admitted for acute myocardial infarction, a study found.
The FDA recently approved a new indication for the Nova StatStrip Glucose Hospital Meter System, extending its use to critically ill patients who have been hospitalized.
A once-daily combination pill of dapagliflozin and metformin HCl extended-release (Xigduo XR) was recently approved by the FDA.